This article is more than 5 years old. Information may no longer be current.

Angle-supported phakic IOL shows absence of long-term complications

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Antonio Marinho

ROME — An angle-supported phakic IOL has good refractive results, is well-tolerated and shows no long-term complications, according to a surgeon speaking here.

Antonio Marinho, MD, spoke about the AcrySof Cachet (Alcon) at the International Society of Refractive Surgery symposium hosted by the Italian Society of Cataract and Refractive Surgery.

"Sizing is, of course, very important. We use the anterior chamber [optical coherence tomography], but also the IOLMaster (Carl Zeiss Meditec), the Orbscan (Bausch + Lomb) or Pentacam (Oculus) can be used," he said.

Most of the lenses that he used in the 2-year study of 62 eyes were 12.5 mm to 13 mm. No case of pupil stretching was reported, and the IOLs were well-positioned at a safe distance from the endothelium and the crystalline lens.

"The mean distance of the lens apex from the endothelium was 1.99 mm (66% of anterior chamber depth); mean distance from the crystalline lens was 0.78 mm (24% of anterior chamber depth); and the mean distance of the IOL edge to the endothelium was 1.35 mm (43% of anterior chamber depth). The endothelial cell count was stable at 2 years," Dr. Marinho said.

Dr. Marinho also implanted five eyes within the European study with this lens, and these eyes have a follow-up of 6 years, with stable results and no complications.

• Disclosure: Dr. Marinho has no direct financial interest in the products discussed in this article, nor is he a paid consultant for any companies mentioned.